Your browser doesn't support javascript.
loading
Safety and immunogenicity of SpikoGen®, an Advax-CpG55.2-adjuvanted SARS-CoV-2 spike protein vaccine: a phase 2 randomized placebo-controlled trial in both seropositive and seronegative populations.
Tabarsi, Payam; Anjidani, Nassim; Shahpari, Ramin; Mardani, Masoud; Sabzvari, Araz; Yazdani, Babak; Roshanzamir, Khashayar; Bayatani, Behnam; Taheri, Ali; Petrovsky, Nikolai; Li, Lei; Barati, Saghar.
Afiliação
  • Tabarsi P; Clinical Tuberculosis and Epidemiology Research Centre, National Research Institute for Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Anjidani N; Medical Department, Orchid Pharmed Company, Tehran, Iran.
  • Shahpari R; Medical Department, Orchid Pharmed Company, Tehran, Iran.
  • Mardani M; Infectious Disease and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Sabzvari A; Medical Department, Orchid Pharmed Company, Tehran, Iran.
  • Yazdani B; Medical Department, Orchid Pharmed Company, Tehran, Iran.
  • Roshanzamir K; CinnaGen Medical Biotechnology Research Center, Alborz University of Medical Sciences, Karaj, Iran.
  • Bayatani B; Medical Department, Orchid Pharmed Company, Tehran, Iran.
  • Taheri A; Medical Department, Orchid Pharmed Company, Tehran, Iran.
  • Petrovsky N; Vaxine Pty Ltd, Bedford Park, Adelaide, Australia.
  • Li L; Vaxine Pty Ltd, Bedford Park, Adelaide, Australia.
  • Barati S; Medical Department, Orchid Pharmed Company, Tehran, Iran. Electronic address: Barati.S@orchidpharmed.com.
Clin Microbiol Infect ; 28(9): 1263-1271, 2022 Sep.
Article em En | MEDLINE | ID: mdl-35436611

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Clin Microbiol Infect Assunto da revista: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Irã País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Clin Microbiol Infect Assunto da revista: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Irã País de publicação: Reino Unido